Biocon Dirección
Dirección controles de criterios 4/4
El CEO de Biocon es Siddharth Mittal , nombrado en Dec 2019, tiene una permanencia de 4.92 años. compensación anual total es ₹57.31M, compuesta por 100% salario y 0% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.069% de las acciones de la empresa, por valor de ₹268.40M. La antigüedad media del equipo directivo y de la junta directiva es de 2.3 años y 3 años, respectivamente.
Información clave
Siddharth Mittal
Chief Executive Officer (CEO)
₹57.3m
Compensación total
| Porcentaje del salario del CEO | 100.0% |
| Permanencia del CEO | 4.9yrs |
| Participación del CEO | 0.07% |
| Permanencia media de la dirección | 2.3yrs |
| Promedio de permanencia en la Junta Directiva | 3yrs |
Actualizaciones recientes de la dirección
Recent updates
Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results
Nov 02
Why Investors Shouldn't Be Surprised By Biocon Limited's (NSE:BIOCON) Low P/E
Nov 01Do Biocon's (NSE:BIOCON) Earnings Warrant Your Attention?
Oct 14These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Sep 20Biocon Limited's (NSE:BIOCON) Earnings Haven't Escaped The Attention Of Investors
Jun 29Is Biocon (NSE:BIOCON) A Risky Investment?
Jun 11Biocon (NSE:BIOCON) Is Reducing Its Dividend To ₹0.50
Jun 11Biocon's (NSE:BIOCON) Promising Earnings May Rest On Soft Foundations
May 24Biocon's (NSE:BIOCON) Dividend Is Being Reduced To ₹0.50
May 23Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?
Mar 20Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next
Feb 12Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 18% Below Its Share Price
Jan 23Shareholders Should Be Pleased With Biocon Limited's (NSE:BIOCON) Price
Jan 03These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Nov 13Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)
Aug 03Biocon (NSE:BIOCON) Will Pay A Larger Dividend Than Last Year At ₹1.50
Jul 03Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 02Biocon's (NSE:BIOCON) Dividend Will Be Increased To ₹1.50
May 26Estimating The Fair Value Of Biocon Limited (NSE:BIOCON)
Mar 28Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly
Feb 26Biocon Limited (NSE:BIOCON) Shares Could Be 24% Above Their Intrinsic Value Estimate
Dec 17Is There An Opportunity With Biocon Limited's (NSE:BIOCON) 46% Undervaluation?
Sep 05Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 13Biocon Limited (NSE:BIOCON) Shares Could Be 20% Below Their Intrinsic Value Estimate
May 26Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹14b |
| Jun 30 2024 | n/a | n/a | ₹16b |
| Mar 31 2024 | ₹57m | ₹57m | ₹10b |
| Dec 31 2023 | n/a | n/a | ₹12b |
| Sep 30 2023 | n/a | n/a | ₹5b |
| Jun 30 2023 | n/a | n/a | ₹4b |
| Mar 31 2023 | ₹48m | ₹48m | ₹5b |
| Dec 31 2022 | n/a | n/a | ₹4b |
| Sep 30 2022 | n/a | n/a | ₹6b |
| Jun 30 2022 | n/a | n/a | ₹7b |
| Mar 31 2022 | ₹42m | ₹42m | ₹6b |
| Dec 31 2021 | n/a | n/a | ₹7b |
| Sep 30 2021 | n/a | n/a | ₹7b |
| Jun 30 2021 | n/a | n/a | ₹7b |
| Mar 31 2021 | ₹43m | ₹43m | ₹7b |
| Dec 31 2020 | n/a | n/a | ₹6b |
| Sep 30 2020 | n/a | n/a | ₹6b |
| Jun 30 2020 | n/a | n/a | ₹7b |
| Mar 31 2020 | ₹49m | ₹31m | ₹8b |
Compensación vs. Mercado: La compensación total ($USD678.26K) de Siddharth está en línea con el promedio de empresas de tamaño similar en el mercado Indian ($USD589.97K).
Compensación vs. Ingresos: La compensación de Siddharth ha sido consistente con los resultados de la empresa en el último año.
CEO
Siddharth Mittal (46 yo)
4.9yrs
Permanencia
₹57,310,000
Compensación
Mr. Siddharth Mittal, BCom, CA, CPA has been CEO and Director of Biocon Limited since December 1, 2019. He has been Managing Director of Biocon Limited since April 01, 2020 and served as its Joint Managing...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder & Executive Chairperson | 46yrs | ₹38.43m | 40.49% ₹ 156.6b | |
| MD, CEO & Director | 4.9yrs | ₹57.31m | 0.069% ₹ 268.4m | |
| Group Chief Executive Officer | 1.2yrs | ₹1.91m | sin datos | |
| Chief Financial Officer | less than a year | sin datos | sin datos | |
| Head of Operations | 1.6yrs | sin datos | sin datos | |
| Group Chief Information Officer | 4.2yrs | sin datos | sin datos | |
| Head of Investor Relations | 2.3yrs | sin datos | sin datos | |
| Company Secretary & Compliance Officer | 5.3yrs | ₹5.75m | sin datos | |
| Global Head of Communications & Corporate Brand | no data | sin datos | sin datos | |
| Head of Human Resources | no data | sin datos | sin datos | |
| Chief Commercial Officer | no data | sin datos | sin datos | |
| Commercial Head of Biocon Global Generics | no data | sin datos | 0.019% ₹ 71.8m |
2.3yrs
Permanencia media
54.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de BIOCON se considera experimentado (2.3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder & Executive Chairperson | 46yrs | ₹38.43m | 40.49% ₹ 156.6b | |
| MD, CEO & Director | 4.9yrs | ₹57.31m | 0.069% ₹ 268.4m | |
| Non-Executive Non-Independent Director | 24.3yrs | ₹6.23m | 0.44% ₹ 1.7b | |
| Independent Non-Executive Director | 6.3yrs | ₹7.81m | sin datos | |
| Additional Non-Executive Independent Director | 2.6yrs | ₹6.24m | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | less than a year | ₹5.20m | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 1.3yrs | ₹5.70m | sin datos | |
| Non-Executive Director | 3yrs | ₹5.57m | 0.27% ₹ 1.0b | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Non-Executive and Independent Director | less than a year | sin datos | sin datos |
3.0yrs
Permanencia media
62.5yo
Promedio de edad
Junta con experiencia: La junta directiva de BIOCON se considera experimentada (3 años de antigüedad promedio).